7th December 2020
Cambridge, UK – 7 December 2020: Nuformix plc (LSE:NFX; “Nuformix”, the “Company” or the “Group”), a drug re-purposing specialist, is pleased to announce the appointment of Dr Anne Brindley as Chief Executive Officer “CEO” and Executive Director of the Company with immediate effect. Download News